Open company graph database — free web & API
Login

JPMA General Incorporated Foundation Japan Placenta Medical Association

JPMA 一般財団法人 日本プラセンタ医学会一般財団法人 日本プラセンタ医学会Alias
Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
13
§01

Basic information

BASIC
Head office
404, 6-4-5 Tsukiji, Chuo-ku, Tokyo 104-0045Sources
Chief executive
Mitsunobu NakamuraSources
Capital
Employees (non-consolidated)
Employees (consolidated)
Start date
2013-04-01
End date
§02

Websites

1 DOMAINS
§03

Business

5
Holding academic conferences and lecturesSourcesHolding training sessionsSourcesEditing and publishing the institutional journalSourcesPublishing booksSourcesEngaging with related domestic and international societies and organizationsSources
§04

Related companies

13 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Klassie Pharmaceutical Co., Ltd. Sources
Supplier
Snowden Corporation Sources
Supplier
Melsmon Pharmaceutical Co., Ltd. Sources
Supplier
Hokkaido Natural Bio Group Inc. Sources
Supplier
Japan Biological Products Co., Ltd. Sources
Supplier
FRACORA Co., Ltd. Sources
Supplier
UTP Corporation Sources
Supplier
Wellheart Co., Ltd. Sources
Supplier
セイリン株式会社 Sources
Alliance
Japan Blind Soccer Association (Non-Profit Organization)
日本東方医学会
日本胎盤臨床医学会
Healthy Pass Corporation
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

11 EVENTS

In 2007, the Japan Placental Clinical Research Society was established. The background of its founding was the increasing prevalence of chronic diseases due to an aging society and the growing need for preventive medicine. The society aimed to enable more physicians to use placental therapy correctly, which could meet these social needs. To achieve this, physicians with similar goals gathered, shared experiences and research findings, and exchanged information.Sources

The first conference of the Japan Placental Clinical Research Society was held in April 2007, and it has been held twice a year since then.Sources

In 2007, the Japan Placental Clinical Research Society was established. The background of its founding was the increasing prevalence of chronic diseases due to an aging society and the growing need for preventive medicine. The society aimed to enable more physicians to use placental therapy correctly, which could meet these social needs. To achieve this, physicians with similar goals gathered, shared experiences and research findings, and exchanged information.Sources

In 2010, three years after the society’s founding, the conference, held twice a year, was enhanced. Small study groups, legal and financial seminars were held in various locations to respond to new circumstances, and the dental subcommittee was established following the start of use in the dental field.Sources

In 2013, the organization changed its name from an informal group to a general incorporated foundation, and from a research society to a medical society.Sources

In 2013, the organization changed its name from an informal group to a general incorporated foundation, and from a research society to a medical society. The society entered its seventh year of operation, and as preventive medicine and geriatric care gained attention, the demand for placental products increased with growing interest in beauty and wellness. The society’s role evolved from an information exchange forum to a position of new social responsibility. To address these societal changes, a "certified physician qualification system" was also established to help patients choose appropriate physicians.Sources

Establishment date: April 1, 2013Sources

Starting in 2014, the JHFA mark, a standard set by the Public Interest Incorporated Foundation Japan Health and Nutrition Food Association, began to be used, initiating self-regulation.Sources

In the rapidly expanding placental market (health foods and beauty cosmetics), the JHFA mark, a standard set by the Public Interest Incorporated Foundation Japan Health and Nutrition Food Association, began to be used in 2014, initiating self-regulation. Following this, the Japan Placental Clinical Medical Society began clinical studies of combined therapies with supplements.Sources

In 2023, the society’s name was changed from the Japan Placental Clinical Medical Society to the Japan Placenta Medical Association.Sources

In 2023, the society’s name was changed from the Japan Placental Clinical Medical Society to the Japan Placenta Medical Association. The society has continued its academic focus on the mechanisms of placental therapy, primarily for disease treatment, and on clinical research, making it appropriate to use "placenta" in an academic and medical context.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑